These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells. Sanada F; Kanbara Y; Taniyama Y; Otsu R; Carracedo M; Ikeda-Iwabu Y; Muratsu J; Sugimoto K; Yamamoto K; Rakugi H; Morishita R Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):545-52. PubMed ID: 26769045 [TBL] [Abstract][Full Text] [Related]
24. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. Jiang M; Wang B; Wang C; He B; Fan H; Guo TB; Shao Q; Gao L; Liu Y J Cell Biochem; 2008 Jan; 103(1):321-34. PubMed ID: 17541946 [TBL] [Abstract][Full Text] [Related]
25. Ultrasound molecular imaging of angiogenesis induced by mutant forms of hypoxia-inducible factor-1α. Xie J; Liao Y; Yang L; Wu J; Liu C; Xuan W; Li M; Zhang L; Liu Y; Wu P; Bin J Cardiovasc Res; 2011 Nov; 92(2):256-66. PubMed ID: 21859818 [TBL] [Abstract][Full Text] [Related]
26. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis. Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097 [TBL] [Abstract][Full Text] [Related]
27. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha. Shibata A; Nakagawa K; Sookwong P; Tsuduki T; Tomita S; Shirakawa H; Komai M; Miyazawa T J Nutr; 2008 Nov; 138(11):2136-42. PubMed ID: 18936210 [TBL] [Abstract][Full Text] [Related]
28. The transcription factor HoxB5 stimulates vascular remodelling in a cytokine-dependent manner. Fessner A; Esser JS; Bluhm F; Grundmann S; Zhou Q; Patterson C; Bode C; Moser M Cardiovasc Res; 2014 Feb; 101(2):247-55. PubMed ID: 24189625 [TBL] [Abstract][Full Text] [Related]
29. TNF stimulation induces VHL overexpression and impairs angiogenic potential in skeletal muscle myocytes. Basic VT; Jacobsen A; Sirsjö A; Abdel-Halim SM Int J Mol Med; 2014 Jul; 34(1):228-36. PubMed ID: 24820910 [TBL] [Abstract][Full Text] [Related]
30. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR. Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169 [TBL] [Abstract][Full Text] [Related]
31. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth. Gacche RN; Meshram RJ Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944 [TBL] [Abstract][Full Text] [Related]
32. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Knowles HJ; Tian YM; Mole DR; Harris AL Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023 [TBL] [Abstract][Full Text] [Related]